Samuel Henderson

Direttore Tecnico/Scientifico/R&S presso Cerecin, Inc.

Consumer Services

Health Technology

Profilo

Samuel Henderson is currently the Chief Scientific Officer at Cerecin, Inc. Previously, he worked as a Principal at The University of Colorado and as a Lead Scientist at Genoplex, Inc. He completed his undergraduate degree at the University of Washington and obtained his doctorate from the University of Chicago.

Posizioni attive di Samuel Henderson

Società	Posizione	Inizio
Cerecin, Inc. Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.	Direttore Tecnico/Scientifico/R&S	-

Tutte le posizioni attive di Samuel Henderson

Precedenti posizioni note di Samuel Henderson

Società	Posizione	Fine
Genoplex, Inc.	Direttore Tecnico/Scientifico/R&S	-
The University of Colorado	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Samuel Henderson

Formazione di Samuel Henderson

University of Washington	Undergraduate Degree
The University of Chicago	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Samuel Henderson

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Cerecin, Inc. Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.	Health Technology
Genoplex, Inc.